11-17 of 17 results
-
ISAPP provides guidance on use of probiotics and prebiotics in time of COVID-19
By ISAPP board of directors Summary: No probiotics or prebiotics have been shown to prevent or treat COVID-19 or inhibit the… -
Safety and efficacy of probiotics: Perspectives on JAMA viewpoint
By Mary Ellen Sanders PhD, executive science officer, ISAPP, and Daniel Merenstein MD, Department of Family Medicine, Georgetown University School… -
The FDA’s view on the term probiotics, part 2: Further down the rabbit hole
By James Heimbach, Ph.D., F.A.C.N., JHEIMBACH LLC, Port Royal, VA A number of weeks ago I wrote on the ISAPP… -
The past decade of probiotics and prebiotics research: ISAPP board members share their perspectives.
By ISAPP board members, compiled by Kristina Campbell Scientific progress in the field of probiotics and prebiotics, as in any… -
Misleading press about probiotics: ISAPP responses
It seems over the last couple of years, open season on “probiotics” has been declared. Responding in a scientifically accurate… -
Effects of the food matrix on probiotic’s efficacy: how much should we care?
By Gabriel Vinderola PhD, Researcher at the Dairy Products Institute (National Scientific and Technical Research Council – CONICET) and Associate… -
Efficacy and Effectiveness Studies
By Michael D. Cabana, MD, MPH In the world of clinical trials, reproducibility (or consistency) of results across different clinical…